iMedrix provides diagnostic solutions producing clinical grade ECG traces with device accuracy proved in more than 450,000 ECGs across 15 countries. iMedrix is committed to revolutionising cardiac health care with its Artificial intelligence (AI), Cloud Technology, and Machine learning (ML) for quick diagnosis and accurate clinical decisions.
iMedrix provides cutting-edge medical technology through KardioScreen, a totally mobile, connected 12 & 6 lead, US FDA-cleared electrocardiogram (ECG or EKG).
“KardioScreen from iMedrix is an innovative, US FDA cleared, mobile-connected ECG/EKG device that simplifies the process of heart monitoring and risk assessment in a wide variety of in-hospital, emergency response, home care, primary care and outreach settings.
Company Details
- Employees
- 26
- Founded
- -
- Address
- Mccarthy Blvd,
- Industry
- Medical Device
- Website
- https://www.imedrix.com/
- Keywords
- Cardiac Care, heart health, Heart, Heart Diagnosis.
- HQ
- Milpitas, California
Imedrix Inc. Questions
Imedrix Inc.'s website is https://www.imedrix.com/
Imedrix Inc.'s LinkedIn profile is https://www.linkedin.com/company/imedrix-inc
Imedrix Inc. has
26 employees.
View email and phone details for 26
employees at Imedrix Inc..
Imedrix Inc.'s industry is
Medical Device
Imedrix Inc.'s top competitors are
Nanobiofab,
Synergie Group Pte. Ltd.,
Innaccel,
Infosys,
Imedrix Diagnostics Corporation,
Space (Medtech) Pte. Ltd.,
Agatsa,
Health4silvers,
Origin Medical Research Lab,
Aiila Innovations.
Imedrix Inc.'s categories are Medical Device
Imedrix Inc.'s founding year is 2017
